Literature DB >> 20101482

Design and formulation of mebeverine HCl semisolid formulations for intraorally administration.

Esra Baloğlu1, Sinem Y Karavana, Ismail Yuksel Hyusein, Timur Köse.   

Abstract

Gel formulations of mebeverine hydrochloride (MbHCl) containing hydroxypropylmethylcellulose (HPMC), metolose (MTL), and poloxamer 407 (PLX) were prepared to be used in the treatment of different oral painful conditions. HPMC was used as a mucoadhesive gel base while MTL and PLX were used to prepare sol-gel thermosensitive gels. MTL and PLX formulations showed proper sol-gel transition temperature for intraoral application. Formulations were evaluated in terms of their viscosity, mechanical properties, mucoadhesivity, stability, and in vitro drug release. The formulation prepared with 2% of HPMC K100M provided the highest viscosity at room temperature. However, the viscosity of HPMC-PLX mixture showed a significant increase at body temperature. The greatest mucoadhesion was also noted in HPMC-PLX combinations. Texture profile analysis exhibited the differences of the adhesion, hardness, elasticity, cohesiveness, and compressibility of the formulations. The release profiles of MbHCl were obtained, and non-Fickian release was observed from all the formulations. The formulations were stored at different temperature and relative humidity. No significant changes were observed at the end of the 3 months. HPMC-PLX formulation of MbHCl was chosen for in vivo studies, and it remained longer than dye solution on the rabbit's intraoral mucosal tissue. It was found worthy of further clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101482      PMCID: PMC2850482          DOI: 10.1208/s12249-009-9374-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  22 in total

1.  Potential application of Metolose in a thermoresponsive transdermal therapeutic system.

Authors:  G Csóka; A Gelencsér; A Makó; S Marton; R Zelkó; I Klebovich; I Antal
Journal:  Int J Pharm       Date:  2007-01-19       Impact factor: 5.875

2.  Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties.

Authors:  Marcos L Bruschi; David S Jones; Heitor Panzeri; Maria P D Gremião; Osvaldo de Freitas; Elza H G Lara
Journal:  J Pharm Sci       Date:  2007-08       Impact factor: 3.534

3.  A bioadhesive delivery system as an alternative to infiltration anesthesia.

Authors:  C P Taware; S Mazumdar; M Pendharkar; M H Adani; P V Devarajan
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-12

4.  The action of mebeverine and metabolites on mammalian non-myelinated nerve fibres.

Authors:  A Den Hertog; J Van den Akker
Journal:  Eur J Pharmacol       Date:  1987-07-23       Impact factor: 4.432

5.  Formulation of an antispasmodic drug as a topical local anesthetic.

Authors:  Sameh M Abdel-Hamid; S E Abdel-Hady; A A El-Shamy; H F El-Dessouky
Journal:  Int J Pharm       Date:  2006-07-22       Impact factor: 5.875

6.  Physicochemical characterization and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis.

Authors:  D S Jones; C R Irwin; A D Woolfson; J Djokic; V Adams
Journal:  J Pharm Sci       Date:  1999-06       Impact factor: 3.534

7.  Analysis of Fickian and non-Fickian drug release from polymers.

Authors:  N A Peppas
Journal:  Pharm Acta Helv       Date:  1985

8.  Effect of additives on the physicochemical properties of liquid suppository bases.

Authors:  H Choi; M Lee; M Kim; C Kim
Journal:  Int J Pharm       Date:  1999-11-10       Impact factor: 5.875

9.  Topical anaesthesia of gingival mucosa by 5% eutectic mixture of lignocaine and prilocaine or by 10% lignocaine spray.

Authors:  J Haasio; T Jokinen; M Numminen; P H Rosenberg
Journal:  Br J Oral Maxillofac Surg       Date:  1990-04       Impact factor: 1.651

10.  Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus.

Authors:  S Collaud; T Warloe; O Jordan; R Gurny; N Lange
Journal:  J Control Release       Date:  2007-08-23       Impact factor: 9.776

View more
  6 in total

1.  Periodontal thermoresponsive, mucoadhesive dual antimicrobial loaded in-situ gel for the treatment of periodontal disease: Preparation, in-vitro characterization and antimicrobial study.

Authors:  Monika Bansal; Neelam Mittal; Sarita Kumari Yadav; Gayasuddin Khan; Pooja Gupta; Brahmeshwar Mishra; Gopal Nath
Journal:  J Oral Biol Craniofac Res       Date:  2017-12-13

2.  Gelatin Promotes Cell Retention Within Decellularized Heart Extracellular Matrix Vasculature and Parenchyma.

Authors:  Karis R Tang-Quan; Yutao Xi; Camila Hochman-Mendez; Qian Xiang; Po-Feng Lee; Luiz C Sampaio; Doris A Taylor
Journal:  Cell Mol Bioeng       Date:  2020-07-27       Impact factor: 2.321

3.  Nanohybrid hydrogels designed for transbuccal anesthesia.

Authors:  Lígia Nunes de Morais Ribeiro; Michelle Franz-Montan; Márcia Cristina Breitkreitz; Gustavo Henrique Rodrigues da Silva; Simone Ramos de Castro; Viviane Aparecida Guilherme; Daniele Ribeiro de Araújo; Eneida de Paula
Journal:  Int J Nanomedicine       Date:  2018-10-15

4.  Adenosine diphosphate-decorated chitosan nanoparticles shorten blood clotting times, influencing the structures and varying the mechanical properties of the clots.

Authors:  Tze-Wen Chung; Pei-Yi Lin; Shoei-Shen Wang; Yen-Fung Chen
Journal:  Int J Nanomedicine       Date:  2014-03-31

5.  Optimization and characterization of chitosan films for transdermal delivery of ondansetron.

Authors:  Aslı Sedef Can; Meryem Sedef Erdal; Sevgi Güngör; Yıldız Özsoy
Journal:  Molecules       Date:  2013-05-10       Impact factor: 4.411

6.  Smart Injectable Chitosan Hydrogels Loaded with 5-Fluorouracil for the Treatment of Breast Cancer.

Authors:  Ahmed A H Abdellatif; Ahmed M Mohammed; Imran Saleem; Mansour Alsharidah; Osamah Al Rugaie; Fatma Ahmed; Shaaban K Osman
Journal:  Pharmaceutics       Date:  2022-03-17       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.